Clinical trial

Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)

NCT00726713

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-06-01

PhasePHASE4

Study timeline

Study start (unknown)2008-06-01Date precision: month

Registry last updated2013-08-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetic Peripheral Neuropathy (DPN)unresolved

Interventions

Metanx (a medical food)OTHER

Metanx placeboOTHER

Sponsors & collaborators

Pamlab, Inc.lead sponsor

Tulane University Health Sciences Centercollaborator

VA Nebraska Western Iowa Health Care Systemcollaborator

Scott and White Hospital & Cliniccollaborator

Dallas Diabetes and Endocrine Centercollaborator

University of Alabama at Birminghamcollaborator

dgd Research, Inc.collaborator

Baylor Health Care Systemcollaborator

Mapped research locations

DallasTexas, United States1 San AntonioTexas, United States1 BirminghamAlabama, United States1 OmahaNebraska, United States1 New OrleansLouisiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00726713 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.